The FDA is set to review Pfizer's coronavirus vaccine for kids 5- to 11-years old

Hello,

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let's get to it...


A boy receives the first dose of the Pfizer/BioNTech COVID-19 vaccine in Tegucigalpa, on September 25, 2021, during a vaccination programme for teens aged 12 to 15
A boy receives the first dose of the Pfizer/BioNTech COVID-19 vaccine in Tegucigalpa, on September 25, 2021.
The Pfizer-BioNTech COVID-19 vaccine is 91% effective in 5- to 11-year-olds, new study results find

See the full story>>


A headshot of Dan Mendelson
Dan Mendelson, Morgan Health's CEO.
The head of JPMorgan's new health bet reveals the 3 decisions that persuaded him to come aboard even after the bank's previous venture flopped

Check it out>>


A customer buys onions at the "Central de Abasto" wholesale market in Mexico City on January 14, 2019. - Some 500,000 people and 62,000 vehicles a day visit the Central de Abasto market on the east side of Mexico City to buy and sell avocados, tomatoes and about 15,000 other products.
A customer buys onions at the "Central de Abasto" wholesale market in Mexico City on January 14, 2019.
Salmonella linked to onions has infected more than 650 people in 37 states, CDC says

Read more now>>


More stories we're reading:


-Leah

Read the original article on Business Insider


from Business Insider https://ift.tt/3EeJt2U
via IFTTT

Comments